Pfizer Inc.
APIXABAN FORMULATIONS
Last updated:
Abstract:
Apixaban pharmaceutical formulation is provided. Also provided is a use of the apixaban formulation in treatment of a thromboembolic disorder.
Status:
Application
Type:
Utility
Filling date:
15 Apr 2019
Issue date:
20 May 2021